Form 4: Journey Medical Corp CEO Sells Shares to Cover Tax Obligations

Claude Maraoui, President & CEO of Journey Medical Corp, sold shares of common stock between March 3rd and March 5th, 2025, to cover tax obligations related to vesting restricted stock units.

Summary

• Claude Maraoui, the President & CEO of Journey Medical Corp, reported the sale of common stock in a Form 4 filing.
• The sales occurred on March 3rd, March 4th, and March 5th, 2025.
• A total of 23,508 shares were sold on March 3rd at an average price of $5.19.
• On March 4th, 28,901 shares were sold at an average price of $5.04.
• Finally, on March 5th, 18,147 shares were sold at an average price of $5.13.
• These sales were conducted by the Issuer to satisfy the Reporting Person's tax withholding obligations related to the vesting of restricted stock units.
• The Reporting Person had no discretion over these sales, which were executed automatically according to the Issuer's corporate policies.
• Following these transactions, Maraoui still beneficially owns 2,092,874 shares of Journey Medical Corp common stock, including restricted stock units that vest over time.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The stock sales are related to tax obligations and don't necessarily reflect a change in the executive's confidence in the company. The CEO still holds a significant number of shares.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates